> Skip repeated content

Lupus Subgroup Responds to Anti-CD22

MedPage Today—April 20, 2018

According to a recent study, the monoclonal antibody epratuzumab could deplete B-cells in patients with concomitant systemic lupus erythematosus (SLE) and Sjogren's syndrome, MedPage Today reported.

HSS rheumatologist Kyriakos A. Kirou, MD, DSc, FACP, who was not involved with the study, commented on the results.

"This finding, if confirmed, may allow for a more patient-targeted approach when treating lupus, a notoriously heterogeneous disease," Dr. Kirou said.

"More epratuzumab studies are needed in patients with SLE and associated Sjogren's syndrome before we can conclude that this treatment is effective in this subgroup of patients," he added.

Read the full article at medpagetoday.com

 

Need Help Finding a Physician?

Call us toll-free at:
+1.877.606.1555

Conditions & Treatments

adult child
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body


Conditions A-Z
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
SEE ALL

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts